Navigation Links
Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014
Date:7/28/2014

BOULDER, Colo., July 28, 2014  Array BioPharma Inc. (Nasdaq:   ARRY) will report financial results for the fourth quarter and full year of fiscal 2014 and hold a conference call to discuss those results on Tuesday, August 12, 2014.  Ron Squarer, Chief Executive Officer and Michael Carruthers, Chief Financial Officer will lead the call.Conference Call InformationDate:Tuesday, August 12, 2014Time:9:00 a.m. Eastern TimeToll-Free:(800) 708-4540Toll:(847) 619-6397Pass Code:37609587Webcast, including Replay and Conference Call Slides: http://investor.arraybiopharma.com/phoenix.zhtml?c=123810&p=irol-irhome About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Seven Phase 3 studies are in progress, or are planned to begin this year. These programs include the wholly-owned hematology drug, filanesib (ARRY-520) for multiple myeloma and two partnered cancer drugs, selumetinib (AstraZeneca) and binimetinib (MEK162 / Novartis).  For more information on Array, please go to www.arraybiopharma.com.

CONTACT:

Tricia Haugeto Array BioPharma Inc.(303) 386-1193thaugeto@arraybiopharma.comLogo - http://photos.prnewswire.com/prnh/20121029/LA02195LOGO  


'/>"/>
SOURCE Array BioPharma Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Positive Trial Results, Completed Acquisitions, and Clearances - Research Report on Dyax, IPC, Array BioPharma, Lexicon Pharmaceuticals, and Wright Medical
2. Array BioPharma Provides Clinical Update On ARRY-614 For Myelodysplastic Syndromes At The 2013 American Society Of Hematology Meeting
3. Array BioPharma Provides Clinical Update On Filanesib (ARRY-520) For Multiple Myeloma At The 2013 American Society of Hematology Meeting
4. Array BioPharma Announces Management Team Change
5. Array BioPharma To Present At The Jefferies 2013 Global Healthcare And Piper Jaffray 25th Annual Healthcare Conferences
6. Array BioPharma To Present Clinical Data At The 2013 ASH Annual Meeting On ARRY-520 For Multiple Myeloma And ARRY-614 For Myelodysplastic Syndromes
7. ARRAYit Corporation Receives Purchase Order from ChemBio
8. Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2014 And Announces ARRY-520 Development Strategy
9. Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2014 On October 31, 2013
10. Arrayit Corporation Announces New Corporate Headquarters in Sunnyvale California
11. ARRAYit Corporation Receives $104,000 Purchase Order from the University of California
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Research and Markets ( ... "Veterinary Pharmaceutical Submissions in the EU (London, ... their offering. This practical two-day course ... parts of the application for marketing authorisation for ... authorisation is sought in the European Union, including ...
(Date:9/4/2015)... 4, 2015 Hutchison China ... Hutchison MediPharma Limited ("HMP"), its drug R&D subsidiary, ... proof-of-concept ("POC") trial of fruquintinib in patients with ... China .  The top-line results ... the primary efficacy endpoint of progression free survival ...
(Date:9/3/2015)... Sept. 3, 2015 With a population of ... country and therefore also its single largest potential market ... China has led all major world economies in the ... expenditures, and government health expenditures. As an in vitro ... markets of the United States, western European countries, and ...
Breaking Medicine Technology:Veterinary Pharmaceutical Submissions in the EU: Two day Course - London, UK - December 7-8, 2015 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13
... (OTC Bulletin Board: ACUR) (the "Company") today announced ... "Agreement"), with an,investor group comprised of Vivo Ventures ... L.P., GCE Holdings LLC and certain individual investors,(the ... Units ("Units") at a price of $1.08 per ...
... 20 Ranbaxy Pharmaceuticals Inc.,(RPI), a wholly owned ... RLL has received approval from the U.S. Food ... and,Acetaminophen Tablets USP, 7.5 mg/750 mg, 10 mg/500 ... The Office of Generic Drugs, U.S. Food and ...
Cached Medicine Technology:Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 2Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate 3Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP 2
(Date:9/5/2015)... PA (PRWEB) , ... September 05, 2015 , ... "I ... period," said one of two inventors from Phoenix, Ariz. "I came up with this ... but to help with rehabilitation too." , They developed the KNEE BUDDY to comfortably ...
(Date:9/5/2015)... , ... September 05, 2015 , ... If you are ... of accidental needle sticks, there is a greater need than ever before for an ... NON SLIP GRIP SYRINGE to protect medical staff members and patients against accidental needle ...
(Date:9/5/2015)... ... September 05, 2015 , ... As school supply lists continue to increase and budgets ... demands for their students. William Mattar Law Offices has found a way to help ... teachers as well as principals and superintendents as in past years. Because of that, ...
(Date:9/4/2015)... ... September 04, 2015 , ... According to an article ... being cared for in nursing homes and assisted living facilities are receiving insufficient care ... story in which her father was at one point close to death, not because ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... According to ... the Journal of the American Dental Association presented data showing that it is safe ... a group of pregnant women that had undergone local anesthesia with a group that ...
Breaking Medicine News(10 mins):Health News:InventHelp Inventor Develops Therapeutic Knee Support (PHO-2061) 2Health News:Safety Feature for Needle Injections Invented by InventHelp Client (OCM-914) 2Health News:‘Pencils 4 Schools’ Campaign 2015 Exceeds Expectations from Previous Year 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2
... ... and Caicos clinical facilities allowing the islands to provide access to medical specialists, improve ... ... supplier of telemedicine technology , devices, and application software for both dynamic encounters ...
... ... successful 57-year old Reno, Nevada, dentist – and mystic! -- has ... that belongs in every spiritual seeker’s library. In ... The Transformation of Spirituality” (Gene Pascucci Publishing, 2010), Pascucci tells his ...
... A study forthcoming in the Journal of Political Economy ... higher death rates in U.K. hospitals. The U.K.,s National ... nation,s health care, sets wages for nurses and other health ... flat throughout the country, despite the fact that wages for ...
... to prevent mistakes, review finds , WEDNESDAY, May 12 (HealthDay ... that caffeine consumption can help night-shift workers avoid making mistakes. ... are thought to be engaged in shift work or permanent ... from shift-work disorder, in which they only sleep for short ...
... that can cause trouble, experts say , WEDNESDAY, May 12 ... to implant and maintain could make life better for people ... report. , A defibrillator delivers an electric shock to restart ... are implanted in Americans each year. Current models require careful ...
... could be a significant predictor of responses to vaccines, ... of Public Health. They examined published data from numerous ... is a fundamental, but often overlooked predictor of vaccine ... infectious disease. The review is featured in the May ...
Cached Medicine News:Health News:AMD Global Telemedicine Inc. Chosen by InterHealth Canada as the Telemedicine Solutions Provider for Turks and Caicos Hospital Project 2Health News:AMD Global Telemedicine Inc. Chosen by InterHealth Canada as the Telemedicine Solutions Provider for Turks and Caicos Hospital Project 3Health News:"What If We're Him?" -- New Book Poses Provocative Perspective on Jesus, God 2Health News:"What If We're Him?" -- New Book Poses Provocative Perspective on Jesus, God 3Health News:Can wage regulation be deadly? 2Health News:New Implanted Defibrillator May Be Simpler, Safer 2Health News:New Implanted Defibrillator May Be Simpler, Safer 3Health News:Response to vaccines could depend on your sex 2
... are designed specifically for medical environments. Resulting ... with professional monitors, the LMD-151MD offer uncompromising ... requirements and are ideal for use in ... Slim and light, they can be used ...
A comprehensive bioresorbable product line comprised of implants and accessories that serve craniomaxillofacial, neurosurgical, and iliac crest reconstruction....
... Major advancement in craniomaxillofacial fixation. Completely resorbable, ... titanium. Today, it is the most thoroughly ... available as LactoSorb SE, with system enhancements ... LactoSorb SEs streamlined delivery system means that ...
1.7/2.2 mm Delta System resorbable implant technology merges science and simplicity for a superior craniomaxillofacial surgery product. The system consists of resorbable bone plates and screws fabric...
Medicine Products: